Pharmaceutical trademarks
Inconsistencies in approach to the test of
likelihood of confusion make it difficult
to evaluate in advance the risks associated
with adopting a pharmaceutical
trademark in Italy.
To read more
Register for free for limited access
Register for free to receive our newsletter, view leading trademark professionals in WTR 1000 and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Subscribe now